Fact 10: Low-dose CT (LDCT) is the established screening tool for people who meet lung cancer screening criteria.
Cizzle Bio is advancing CIZ1B as a biomarker blood test designed to support earlier lung cancer detection as an adjunct tool in clinical assessment.
Fact 9: The U.S. Preventive Services Task Force recommends annual lung cancer screening for adults ages 50 to 80 with a 20 pack-year smoking history who currently smoke or quit within the past 15 years.
Cizzle Bio is proud to announce that CIZ1B has completed laboratory validation at OmniHealth Diagnostics.
This milestone marks a key step toward near-term clinical availability and supports our mission to advance earlier lung cancer detection.
Fact 8: Chronic lung conditions such as COPD or emphysema may increase lung cancer risk.
For individuals with chronic lung conditions, ongoing conversations about lung health and cancer risk are especially important.
#StepUpFor20#LungCancerAwareness#EarlyDetection#CizzleBio
Fact 6: Radon exposure is an important lung cancer risk factor, especially because it can be present in your house even though you can’t see or smell it.
Some risks are invisible. Awareness can help people take practical steps to better understand and protect their lung health.
Fact 5: Smoking is not the only risk factor for lung cancer. People with no smoking history can also be diagnosed.
Lung cancer can affect many different people. Reducing stigma helps create space for earlier conversations, better support, and more compassionate care.
Fact 4: Lung cancer risk can be shaped by smoking history, family history, and chronic lung conditions—as well as exposure to secondhand smoke, radon, asbestos, and air pollution.
Risk is not always simple or tied to one factor.
After losing loved ones to stomach cancer, Priscilla learned she carried a hereditary CDH1 mutation. Her story shows why family history, awareness, and early detection matter. Read her story:
https://t.co/F71akrPzIt
#CancerSurvivorsMonth#StomachCancer#EarlyDetection#CizzleBio
Fact 3: Most lung cancers are non-small cell lung cancer, also known as NSCLC.
Because NSCLC represents the majority of lung cancer cases, tools that support early detection may play an important role in improving how lung cancer is identified and managed.
Fact 2: There are two main types of lung cancer: non-small cell lung cancer and small cell lung cancer. Understanding lung cancer begins with education. The more patients and families know, the better prepared they are to have informed conversations with healthcare providers.